Real-time enrollment status for this melanoma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 9:42 AM UTC
| NCT Number | NCT06624644 |
| Recruiting Status | Recruiting |
| Condition | Melanoma |
| Phase | PHASE2 |
| Target Enrollment | 135 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Linnaeus Therapeutics, Inc. |
| Last Updated on CT.gov | April 22, 2026 (Apr 22, 2026) |
As of October 15, 2026: Clinical trial NCT06624644 is currently recruiting participants. This phase2 study for melanoma is actively seeking new participants at 9 locations across the United States. The study is sponsored by Linnaeus Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06624644 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06624644 was last updated Apr 22, 2026 (April 22, 2026). HelloStudys verifies this status automatically.